It has been reported that RAS signaling can up-regulate tumor cell PD-L1 expression through increasing PD-L1 mRNA stability via modulation of the AU-rich element-binding protein tristetraprolin (Coelho et al., 2017). The gene discussed is ZFP36; the disease is neoplasm.